Mitiglinide

Modify Date: 2024-01-03 20:09:27

Mitiglinide Structure
Mitiglinide structure
Common Name Mitiglinide
CAS Number 145375-43-5 Molecular Weight 315.41
Density 1.2±0.1 g/cm3 Boiling Point 519.6±43.0 °C at 760 mmHg
Molecular Formula C19H25NO3 Melting Point N/A
MSDS N/A Flash Point 268.0±28.2 °C

 Use of Mitiglinide


Mitiglinide (KAD-1229), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide can be used for the research of type 2 diabetes[1][2].

 Names

Name [2(S)-cis]-Octahydro-γ-oxo-α-(phenylmethyl)-2H-isoindole-2-butanoic acid
Synonym More Synonyms

 Mitiglinide Biological Activity

Description Mitiglinide (KAD-1229), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel). Mitiglinide can be used for the research of type 2 diabetes[1][2].
Related Catalog
Target

KATP channel[1]

In Vitro Mitiglinide inhibits the Kir6.2/SUR1 channel currents in a dose-dependent manner (IC50 of 100 nM) but does not significantly inhibit either Kir6.2/SUR2A or Kir6.2/SUR2B channel currents even at high doses (more than 10 μM) in COS-1 cells[1].
In Vivo Mitiglinide (1-3 mg/kg; p.o.) suppresses the increase in plasma glucose levels seen after a meal load and the area under the curve for plasma glucose levels (AUCglucose) up to 5 h after the meal load[2]. Animal Model: Pregnant Wistar rats (12 weeks)[2] Dosage: 0.3 mg/kg, 1 mg/kg, 3 mg/kg Administration: Oral administration Result: Dose-dependently suppressed AUCglucose levels.
References

[1]. Y Sunaga, et al. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide. Eur J Pharmacol. 2001 Nov 9;431(1):119-25.

[2]. Kiyoshi Ichikawa, et al. Effect of KAD-1229, a novel hypoglycaemic agent, on plasma glucose levels after meal load in type 2 diabetic rats. Clin Exp Pharmacol Physiol. May-Jun 2002;29(5-6):423-7.

 Chemical & Physical Properties

Density 1.2±0.1 g/cm3
Boiling Point 519.6±43.0 °C at 760 mmHg
Molecular Formula C19H25NO3
Molecular Weight 315.41
Flash Point 268.0±28.2 °C
Exact Mass 315.183441
PSA 57.61000
LogP 4.73
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.567

 Safety Information

HS Code 2942000000

 Synthetic Route

 Customs

HS Code 2942000000

 Synonyms

Mitiglinide
Unii-D86I0xlb13
(-)-(2S,3a,7a-cis)-α-Benzylhexahydro-γ-oxo-2-isoindolinebutyric acid
(2S)-2-Benzyl-4-((3a,7a-cis)-octahydro-2H-isoindol-2-yl)-4-oxobutanoic Acid
(-)-(2S,3a,7a-cis)-a-Benzylhexahydro-g-oxo-2-isoindolinebutyric Acid
(2S)-2-Benzyl-4-[(3aR,7aS)-octahydro-2H-isoindol-2-yl]-4-oxobutanoic acid
2H-Isoindole-2-butanoic acid, octahydro-γ-oxo-α-(phenylmethyl)-, (αS,3aR,7aS)-
Top Suppliers:I want be here

Get all suppliers and price by the below link:

Mitiglinide suppliers

Mitiglinide price